Navigation Links
Fosamax Lawsuit Update: Bernstein Liebhard LLP Notes Nearly 2,600 Claims Alleging Fosamax Femur Fractures, Other Side Effects, Pending in New Jersey State Litigation
Date:4/14/2013

New York, New York (PRWEB) April 14, 2013

Fosamax lawsuits continue to mount in the consolidated litigation currently underway in New Jersey Superior Court, Bernstein Liebhard LLP reports. A total of 2,599 claims alleging the drug caused users to suffer Fosamax femur fractures and other side effects are currently pending in the litigation, according to the latest case list posted on the Court’s website on April 6th. Court documents indicate that the next Monthly Management Conference in the state Fosamax litigation will be held on May 7th. (In re: Fosamax Litigation, No. 282, N.J. Super. Ct)

“We are pleased to see this litigation moving forward. We are currently representing dozens of women who suffered alleged Fosamax femur fractures and other side effects, and continue to receive inquiries from users of this drug. We look forward to more progress in this proceeding,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The firm is actively filing Fosamax femur fracture lawsuits in the New Jersey Superior Court litigation.

Fosamax Femur Fracture Lawsuits
Fosamax and other bisphosphonates are used to treat bone weakening diseases, including osteoporosis. These medications were the subject of a U.S. Food & Drug Administration (FDA) advisory issued in October 2010, after studies indicated that people taking bisphosphonates for osteoporosis are at risk of suffering atypical femur fractures. The agency advised doctors to be aware of the possible risk associated with Fosamax and similar drugs, and consider periodic reevaluation of the need for continued treatment in patients taking the medications for longer than five years.*

Since the FDA advisory was issued, thousands of Fosamax lawsuits have been filed in state and federal court on behalf of patients who allegedly suffered femur fractures due to long-term use of the drug. In addition to the claims filed in the consolidated Fosamax litigation now underway in New Jersey Superior Court, additional Fosamax femur fracture lawsuits are pending in a multidistrict litigation established in U.S. District Court, District of New Jersey (In re: Fosamax (Alendronate Sodium) Products Liability Litigation (No. II) - MDL No. 2243). Court documents indicate that more than 850 claims are currently pending in the federal Fosamax litigation, and the first trial in that proceeding is currently underway. (Glynn v. Merck Sharp & Dohme Corp., 3:11- cv-05304, U.S. District Court, District of New Jersey)

Victims of alleged Fosamax femur fractures could be entitled to compensation for medical bills, lost wages, pain and suffering, and other damages. A wealth of information regarding Fosamax femur fracture lawsuits is available by visiting Bernstein Liebhard LLP’s website. To arrange for a free case review, please contact Bernstein Liebhard LLP at (877) 779-1414.
*fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm229171.htm

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com

Read the full story at http://www.prweb.com/releases/fosamax-lawsuits/fosamax-femur-fractures/prweb10630486.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New Lawsuit Alleges Fosamax Increases Risk of Injury: Now, AttorneyOne Can Provide Advice
2. The Law Firm of d'Oliveira & Associates Now Offers a No Win - No Fee Promise in Fosamax Cases
3. US Drug Watchdog Now Offers to Help All Woman Who Used Fosamax For Osteoporosis and Then Had an Unexplained a Femur Break Get to the Best Attorneys
4. US Drug Watchdog Now Offers To Help Women Who Used TheOsteoporosis Drug Called Fosamax And Then Had A Unexplainable Femur Fracture Get To The Best Attorneys Or Law Firms
5. Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes New Order Dismissing Endo Entities as Defendants in Federal Vaginal Mesh Litigations
6. Mirena Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on New Mirena IUD Side Effects Study
7. Skechers Fracture Lawsuit Filed on Behalf of an Arizona Woman Who Sustained Multiple Arm Fractures Allegedly Due to Unstable Shape-Ups, by Wright & Schulte
8. First Vaginal Mesh Lawsuit Trials in Federal C.R. Bard Avaulta Mesh Litigation To Begin, Reports Wright & Schulte LLC
9. Zoloft Lawsuits: Bernstein Liebhard LLP Notes More than 300 Claims Now Pending in Federal Zoloft Birth Defects Litigation
10. Medtronic Infuse Bone Graft Lawsuits: Bernstein Liebhard LLP Notes New Report Predicting Hundreds of Medtronic Infuse Lawsuits
11. Stryker Hip Replacement Lawsuit News: Mass. Woman Files First Known Federal Stryker ABG II Hip Lawsuit, Rottenstein Law Group Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser ... Cancer Institute. For Betsy, the clinical trial has been life-saving as she has ... worsened. , Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Mary Magdalene: Grace is ... life of the woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater ... spent her career as an educator interacting with countless women who had little knowledge ...
(Date:1/20/2017)... ... ... a fine examination of how God handles sin, including how to let go of ... who, for over ten long years has been waiting to release this powerful insight about ... has been serving the Lord for over twenty years, and he has been preaching and ...
(Date:1/20/2017)... ... ... and enchanting tale that teaches children the true meaning of Christmas. “Journey to Christmas” is ... a devoted woman of faith. , “Becoming a parent changes you. In my case, ... for years, but actually doing it might have been a while in coming if it ...
(Date:1/20/2017)... ... , ... “God's Miracle Man: Against All Odds”: an inspiring affirmation of ... Keith C. A. Tucker, son of Minister Delores Pinnock and a Jamaican native who ... Hardy , “While sitting up in bed, I felt a pounding headache. It was ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Report Details ... Alzheimer,s Disease Therapeutics and ... our new study reveals trends, R&D progress, and predicted ... the Alzheimer,s disease therapeutics and diagnostics market. Our new ... - How is the Alzheimer,s disease therapeutics and diagnostics ...
(Date:1/19/2017)... , January 19, 2017 Incretin Mimetics/GLP-1 ... and Others The global anti-obesity drugs market ... first half of the forecast period and CAGR of 38.7% in ... to grow at a CAGR of 32.8% from 2016 to 2027. ... in 2021, and $24,063 million in 2027. ...
(Date:1/19/2017)... -- James Gilbart , ... 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ...      ... in a supplement to European Oncology & Haematology ... by James Gilbart and Axel ...
Breaking Medicine Technology: